Clinical indications and outcomes of Impella devices for severe cardiogenic shock in COVID-19 patients: a systematic review
Description
CONCLUSIONS: Sixteen reported individuals have received an Impella implanted with a mortality rate of 11.7%. Concurrent use of RRT and ECMO implantation was often observed. Overall, the Impella device is an effective and safe strategy in the